Used as a diagnostic biomarker and a potential therapeutic target in HCC. Low expression of FTCD is closely related to the poor prognosis, alpha‐fetoprotein (AFP) level, larger tumour size and vascular invasion of HCC. The gene discussed is AFP; the disease is neoplasm.